Belite Bio earnings were -$77.6M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest BLTE earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$25.3M, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BLTE reported annual earnings of -$77.6M, with 114.7% growth.
On BLTE's earnings call on Invalid Date, Belite Bio (NASDAQ: BLTE) reported Q4 2025 earnings per share (EPS) of -$0.71, up 121.88% year over year. Total BLTE earnings for the quarter were -$25.32 million. In the same quarter last year, Belite Bio's earnings per share (EPS) was -$0.32.
As of the last Belite Bio earnings report, Belite Bio is currently losing money. Belite Bio's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$77.61 million, a 114.73% increase year over year.
What was BLTE's earnings growth in the past year?
As of Belite Bio's earnings date in Invalid Date, Belite Bio's earnings has grown year over year. BLTE earnings in the past year totalled -$77.61 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.